Decision Algorithm for Vital Sign Assessment in the Outpatient Physical Therapy Setting

ClinicalTrials.gov ID: NCT07258030

Public ClinicalTrials.gov record NCT07258030. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 28, 2026, 7:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Development of a Decision Algorithm for Vital Sign Assessment in the Outpatient Physical Therapy Setting: An e-Delphi Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Brief Summary The goal of this observational study is to develop consensus-based criteria for when vital sign assessment (VSA) should be performed in outpatient physical therapy settings. The primary purpose is to identify clinical signs, symptoms, and other factors that inform decision-making for VSA to improve patient safety and guide treatment progression. Main Questions: 1. Which clinical characteristics indicate that vital signs should be assessed during outpatient physical therapy? 2. Which clinical characteristics indicate that vital signs do not need to be assessed? Study Design: This study uses a three-round electronic Delphi (e-Delphi) process to achieve expert consensus. Comparison: Researchers will compare responses across rounds to determine agreement and stability of criteria for inclusion in a decision algorithm. Participants: Licensed physical therapists with ≥5 years of clinical experience in outpatient settings. Procedures: Participants will: Complete three rounds of online surveys via Qualtrics. Round 1: Suggest signs, symptoms, and factors for assessing or not assessing vitals. Round 2: Rank importance of these factors on a 5-point Likert scale and suggest additional items. Round 3: Review aggregated results and finalize consensus on criteria.

Study identification

NCT ID: NCT07258030
Recruitment status: Recruiting
Study type: Observational
Phase: Not listed
Lead sponsor: Youngstown State University; Other
Enrollment: 100 participants

Conditions and interventions

Conditions

Healthy

Interventions

E-Delphi Other

Other

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 20, 2025
Primary completion: Mar 30, 2026
Completion: Mar 31, 2026
Last update posted: Dec 1, 2025

2025 – 2026

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Youngstown State University	Youngstown	Ohio	44555	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07258030, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Dec 1, 2025 · Synced Jul 28, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07258030 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →